Suven Pharmaceuticals Limited Stock

Equities

SUVENPHAR

INE03QK01018

Pharmaceuticals

End-of-day quote NSE India S.E. 06:00:00 2024-07-18 pm EDT 5-day change 1st Jan Change
820.6 INR -5.93% Intraday chart for Suven Pharmaceuticals Limited -3.24% +13.53%
Sales 2025 * 11.53B 138M Sales 2026 * 14.7B 176M Capitalization 209B 2.5B
Net income 2025 * 3.4B 40.67M Net income 2026 * 4.56B 54.53M EV / Sales 2025 * 18.1 x
Net cash position 2025 * - 0 Net cash position 2026 * - 0 EV / Sales 2026 * 14.2 x
P/E ratio 2025 *
61.2 x
P/E ratio 2026 *
45.1 x
Employees 1,193
Yield 2025 *
0.18%
Yield 2026 *
0.21%
Free-Float 89.97%
More Fundamentals * Estimated data
Dynamic Chart
1 day-5.93%
1 week-3.24%
Current month+2.06%
1 month+13.33%
3 months+27.31%
6 months+15.85%
Current year+13.53%
More quotes
1 week
815.10
Extreme 815.1
881.60
1 month
696.05
Extreme 696.05
889.70
Current year
585.20
Extreme 585.2
889.70
1 year
480.00
Extreme 480
889.70
3 years
390.50
Extreme 390.5
889.70
5 years
87.60
Extreme 87.6
889.70
10 years
87.60
Extreme 87.6
889.70
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-09-28
Director of Finance/CFO 30 Dec. 31
Director/Board Member - 23-09-28
Members of the board TitleAgeSince
Director/Board Member 67 23-09-28
Director/Board Member 48 Nov. 08
Director/Board Member 62 Nov. 08
More insiders
Date Price Change Volume
24-07-19 820.6 -5.93% 295,063
24-07-18 872.3 +1.60% 538,651
24-07-16 858.6 +2.07% 269,789
24-07-15 841.2 -0.82% 206,371
24-07-12 848.1 -0.70% 287,326

End-of-day quote NSE India S.E., July 18, 2024

More quotes
Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
820.6 INR
Average target price
670.5 INR
Spread / Average Target
-18.29%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock